G2M Appoints Diagnostics Pioneer John Bishop, Former Cepheid CEO, to Its Advisory Board
In a strategic move set to bolster its global ambitions in the in-vitro diagnostics (IVD) space, Genes2Me (G2M), a fast-rising […]
POINT-OF-CARE-DIAGNOSTICS
In a strategic move set to bolster its global ambitions in the in-vitro diagnostics (IVD) space, Genes2Me (G2M), a fast-rising […]
